Therapeutic Features of Mesenchymal Stem Cells and Human Amniotic Epithelial Cells in Multiple Sclerosis

Imbalance in immune responses plays an indispensable role pathogenesis and development of multiple sclerosis (MS), as a neurodegenerative disorder. Current treatments are not always successful preventing MS treating the disease. Stem cell-based cell therapy has provided new window for disorders. cells can regulate system improve axonal remyelination. They be isolated from different origins such bone marrow, embryonic, neural, adipose tissues. However, there is challenge choosing best source stem therapy. Mesenchymal (MSCs) derived have significant immunoregulatory impacts on system. A growing body evidence indicates that tissue umbilical cord suitable obtaining MSCs. Moreover, human amniotic epithelial (hAEC), novel with effects, regenerative low antigenicity, candidate treatment. This chapter discusses therapeutic MSCs hAECs